The Wake Forest Institute for Regenerative Medicine (WFIRM) is proud to be part of a new initiative, supported by an $18 million grant from the U.S. National Science Foundation (NSF), aimed at enhancing global pandemic prediction and prevention capabilities.
Scientists at Sanford Burnham Prebys and the La Jolla Institute for Immunology have revealed a new secret regarding senescence, a cellular state similar to sleep that is more likely to affect aged cells.
The anti-cancer drug olaparib may be effective in treating biochemically recurrent prostate cancer without accompanying hormone therapy for men who have mutations in genes such as BRCA2, according to results of a phase II clinical trial of 51 patients conducted at the Johns Hopkins Kimmel Cancer Center and three other sites.
The College of American Pathologists (CAP), the International Association for the Study of Lung Cancer (IASLC), and the Association for Molecular Pathology (AMP) announced today the open comment period for the revised 2018 evidence-based guideline, “Updated Molecular Testing Guideline for the Selection of Lung Cancer Patients for Treatment With Targeted Tyrosine Kinase Inhibitors.”
In space, fine dining can be an alien experience.
PFAS, or "forever chemicals," are pervasive pollutants that pose severe risks to human health and the environment due to their extreme resistance to degradation. This study introduces four advanced technologies that offer promising solutions for PFAS remediation.
Palatin Technologies, Inc. (NYSE American: PTN), a biopharmaceutical company developing first-in-class medicines based on molecules that modulate the activity of the melanocortin receptor system, today announced that patient dosing has started for the clinical study entitled: BMT-801: A Phase II, Randomized, Double-Blind, Placebo-Controlled, Clinical Study Investigating the Safety, Tolerability, and Effectiveness of the Co-Administration of Bremelanotide with Tirzepatide (GLP-1/GIP) for the Treatment of Obesity (ClinicalTrials.gov Identifier: NCT06565611).
Imagine plants not just sipping nutrients dissolved in water, but actually munching on tiny mineral particles straight from the soil! This groundbreaking study sheds light on how wheat and lettuce aren’t just passive feeders—they actively grab, transport, and utilize solid minerals from their roots all the way to their shoots.
Hot wheels: a stationary track for mice could lead to breakthrough
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research and prevention. These advances are made possible through seamless collaboration between MD Anderson’s world-leading clinicians and scientists, bringing discoveries from the lab to the clinic and back.
A new study from researchers with UCLA Health and collaborating organizations has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH).
Dr. Alice Soragni and her team developed a high throughput organoid screening platform to rapidly establish and screen 3D tumor organoids for cutaneous neurofibromas to find drugs that slow tumor growth.
The University of Pennsylvania and the Parker Institute for Cancer Immunotherapy (PICI) have renewed their collaboration to advance cancer immunotherapy research at Penn Medicine’s Abramson Cancer Center (ACC).
For nearly a century, scientists have waged war on antibiotic-resistant microbes. Michigan State University researchers say they’ve found a new way to prevent it – by unleashing “DNA scavengers” in wastewater treatment plants.
A pioneering study has unveiled the genetic blueprint of Vernicia montana, a plant renowned for its high-value tung oil and ornamental beauty. The research decodes its chromosome-level genome, providing unparalleled insights into its evolution and setting the stage for advanced molecular breeding and sex identification methods.
A significant milestone in horticultural genomics has been reached with the successful decoding of the tetraploid Chinese cherry genome. This study provides essential insights into the genetic factors that influence fruit firmness, a critical trait for enhancing the cherry’s market appeal and transportation durability.
The Endocrine Society today announced it has chosen 14 leading endocrinologists as winners of its prestigious 2025 Laureate Awards, the top honors in the field.
A cutting-edge study reveals the biochemical defense system of the wild lily, Lilium regale, which demonstrates remarkable resistance against Fusarium wilt—a major threat to the floriculture industry. The research uncovers the lily's robust defense mechanisms, spotlighting the critical role of phenylpropanoid metabolism and the regulatory influence of specific transcription factors. These findings offer valuable insights for developing crops with enhanced disease resistance.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right